Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 268 (RNA5SP268)

Target
RNA5SP268
Molecular classification
Other (specifically, pseudogene; non-coding RNA)
01

Overview

**RNA, 5S ribosomal pseudogene 268** (RNA5SP268) is a human pseudogene related to the family of 5S ribosomal RNA genes[2]. 5S ribosomal RNA (5S rRNA) is a ~120 nucleotide structural RNA integral to the large subunit of the ribosome and essential for protein synthesis[1][5]. Unlike its functional gene relatives, RNA5SP268 is a non-coding sequence that does not translate into functional ribosomal RNA or any protein[2]. Pseudogenes like RNA5SP268 arise through gene duplication or retrotransposition but have lost coding potential due to mutations or truncations[4]. While traditionally considered "junk DNA," some pseudogenes are transcriptionally active and can influence gene regulation, such as by acting as *microRNA decoys* or generating *small interfering RNAs* that affect gene silencing pathways in certain contexts[4]. Emerging data implicate general pseudogene expression profiles as potential biomarkers for molecular subtypes and prognosis in cancers, though RNA5SP268 itself is not currently established as a biomarker or disease driver[6]. There are no known drugs or therapeutic approaches directly targeting RNA5SP268, nor are there recognized safety or clinical concerns related to its presence in the human genome. **Summary:** RNA5SP268 is a human 5S ribosomal RNA pseudogene, not a functional therapeutic target, but potentially relevant to research in gene regulation and pseudogene expression analysis in cancer. It has no direct clinical utility or therapeutic relevance as of now.

Other names
RN5S268RNA5SP268RNA, 5S ribosomal 268
02

Mechanism of action

None (not a functional drug target)

03

Biological functions

Potential regulatory role through RNA-mediated mechanisms (not direct functional RNA or protein product)
04

Disease associations

Other (pseudogene expression patterns may be associated with cancer subtypes and prognosis, but specific links for RNA5SP268 are not established)
05

Biomarkers

Expression of pseudogenes, in general, is being studied as cancer biomarkers, but none specific for RNA5SP268 have been established

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 268 (RNA5SP268).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 268 (RNA5SP268).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call